| Intravaginal immunization with HPV vectors induces tissue-resident CD8+ T cell responses. | |
| | |
MedLine Citation:
|
PMID: 23143305 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The induction of persistent intraepithelial CD8+ T cell responses may be key to the development of vaccines against mucosally transmitted pathogens, particularly for sexually transmitted diseases. Here we investigated CD8+ T cell responses in the female mouse cervicovaginal mucosa after intravaginal immunization with human papillomavirus vectors (HPV pseudoviruses) that transiently expressed a model antigen, respiratory syncytial virus (RSV) M/M2, in cervicovaginal keratinocytes. An HPV intravaginal prime/boost with different HPV serotypes induced 10-fold more cervicovaginal antigen-specific CD8+ T cells than priming alone. Antigen-specific T cell numbers decreased only 2-fold after 6 months. Most genital antigen-specific CD8+ T cells were intra- or subepithelial, expressed αE-integrin CD103, produced IFN-γ and TNF-α, and displayed in vivo cytotoxicity. Using a sphingosine-1-phosphate analog (FTY720), we found that the primed CD8+ T cells proliferated in the cervicovaginal mucosa upon HPV intravaginal boost. Intravaginal HPV prime/boost reduced cervicovaginal viral titers 1,000-fold after intravaginal challenge with vaccinia virus expressing the CD8 epitope M2. In contrast, intramuscular prime/boost with an adenovirus type 5 vector induced a higher level of systemic CD8+ T cells but failed to induce intraepithelial CD103+CD8+ T cells or protect against recombinant vaccinia vaginal challenge. Thus, HPV vectors are attractive gene-delivery platforms for inducing durable intraepithelial cervicovaginal CD8+ T cell responses by promoting local proliferation and retention of primed antigen-specific CD8+ T cells. |
| | |
Authors:
|
Nicolas Çuburu; Barney S Graham; Christopher B Buck; Rhonda C Kines; Yuk-Ying S Pang; Patricia M Day; Douglas R Lowy; John T Schiller |
Related Documents
:
|
2091615 - Role of smooth-muscle cells and macrophages in cardiac allograft arteriosclerosis in ra... 23660515 - The impact of ageing on natural killer cell function and potential consequences for hea... 16043095 - Noggin improves bone healing elicited by muscle stem cells expressing inducible bmp4. 19170985 - Production assistance for cellular therapies (pact): four-year experience from the unit... 21061445 - Il-2-activated haploidentical nk cells restore nkg2d-mediated nk-cell cytotoxicity in n... 8911765 - Persistence of multipotential progenitors in the juvenile rat subventricular zone. |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Intramural Date: 2012-11-12 |
Journal Detail:
|
Title: The Journal of clinical investigation Volume: 122 ISSN: 1558-8238 ISO Abbreviation: J. Clin. Invest. Publication Date: 2012 Dec |
Date Detail:
|
Created Date: 2012-12-03 Completed Date: 2013-02-04 Revised Date: 2013-02-20 |
Medline Journal Info:
|
Nlm Unique ID: 7802877 Medline TA: J Clin Invest Country: United States |
Other Details:
|
Languages: eng Pagination: 4606-20 Citation Subset: AIM; IM |
Affiliation:
|
Laboratory of Cellular Oncology, National Cancer Institute, NIH, Bethesda, Maryland 20892, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Administration, Intravaginal Animals Antigens, Viral / biosynthesis CD8-Positive T-Lymphocytes / immunology*, metabolism, physiology Cell Proliferation Cytotoxicity, Immunologic Female Genes, Reporter Genetic Vectors HEK293 Cells Human papillomavirus 16 / genetics*, immunology Humans Immunization, Secondary Immunologic Memory Interferon-gamma / metabolism Luciferases, Firefly / biosynthesis, genetics Lymph Nodes / immunology Mice Mice, Inbred BALB C Mucous Membrane / immunology, virology Papillomavirus Vaccines / administration & dosage*, genetics Respiratory Syncytial Virus Infections / prevention & control Respiratory Syncytial Viruses / immunology Spleen / immunology Statistics, Nonparametric Tumor Necrosis Factor-alpha / metabolism Vaccination* Vaccines, Synthetic / administration & dosage, genetics Vaccinia virus / genetics, immunology Vagina / immunology, virology |
| Chemical | |
Reg. No./Substance:
|
0/Antigens, Viral; 0/Papillomavirus Vaccines; 0/Tumor Necrosis Factor-alpha; 0/Vaccines, Synthetic; 82115-62-6/Interferon-gamma; EC 1.13.12.7/Luciferases, Firefly |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Mapping immune processes in intact tissues at cellular resolution.
Next Document: ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growth.